Healthcare provider profile · identity verified

Bryan R Reid, MD

Family Practice · CARLISLE, PA · NPI 1366433708

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	635	202
Amlodipine Besylate	Amlodipine Besylate	604	175
Rosuvastatin Calcium	Rosuvastatin Calcium	503	146
Lisinopril	Lisinopril	465	149
Metoprolol Succinate	Metoprolol Succinate	286	82
Levothyroxine Sodium	Levothyroxine Sodium	285	84
Metformin Hcl Er	Metformin Hcl	235	72
Pantoprazole Sodium	Pantoprazole Sodium	225	77
Losartan Potassium	Losartan Potassium	220	72
Hydrochlorothiazide	Hydrochlorothiazide	189	64
Omeprazole	Omeprazole	178	56
Gabapentin	Gabapentin	164	48
Simvastatin	Simvastatin	163	54
Olmesartan Medoxomil	Olmesartan Medoxomil	156	53
Alendronate Sodium	Alendronate Sodium	151	50
Tramadol Hcl	Tramadol Hcl	133	37
Pravastatin Sodium	Pravastatin Sodium	127	39
Jardiance	Empagliflozin	126	39
Furosemide	Furosemide	125	40
Famotidine	Famotidine	122	40
Escitalopram Oxalate	Escitalopram Oxalate	110	33
Bupropion Xl	Bupropion Hcl	107	31
Metformin Hcl	Metformin Hcl	104	38
Allopurinol	Allopurinol	103	31
Buspirone Hcl	Buspirone Hcl	99	32
Trazodone Hcl	Trazodone Hcl	98	35
Clopidogrel	Clopidogrel Bisulfate	97	29
Lorazepam	Lorazepam	97	28
Metoprolol Tartrate	Metoprolol Tartrate	95	29
Fluticasone Propionate	Fluticasone Propionate	94	34
Shingrix	Varicella-Zoster Ge/As01b/Pf	94	71
Pioglitazone Hcl	Pioglitazone Hcl	92	26
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	90	90
Hydralazine Hcl	Hydralazine Hcl	90	25
Atenolol	Atenolol	88	27
Sertraline Hcl	Sertraline Hcl	87	28
Eliquis	Apixaban	86	23
Ezetimibe	Ezetimibe	84	27
Montelukast Sodium	Montelukast Sodium	82	31
Mirtazapine	Mirtazapine	81	20
Carvedilol	Carvedilol	76	23
Albuterol Sulfate Hfa	Albuterol Sulfate	75	43
Meloxicam	Meloxicam	74	24
Glimepiride	Glimepiride	71	24
Tamsulosin Hcl	Tamsulosin Hcl	68	21
Duloxetine Hcl	Duloxetine Hcl	67	16
Fluoxetine Hcl	Fluoxetine Hcl	67	20
Citalopram Hbr	Citalopram Hydrobromide	66	21
Glipizide Er	Glipizide	65	21
Bumetanide	Bumetanide	64	20
Potassium Chloride	Potassium Chloride	57	21
Venlafaxine Hcl Er	Venlafaxine Hcl	57	13
Oxycodone Hcl	Oxycodone Hcl	55	suppressed
Warfarin Sodium	Warfarin Sodium	54	16
Pregabalin	Pregabalin	50	16
Synthroid	Levothyroxine Sodium	50	15
Isosorbide Mononitrate Er	Isosorbide Mononitrate	47	12
Clonazepam	Clonazepam	45	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	43	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	43	13
Terazosin Hcl	Terazosin Hcl	43	11
Donepezil Hcl	Donepezil Hcl	41	12
Prednisone	Prednisone	40	32
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	39	39
Benazepril Hcl	Benazepril Hcl	37	11
Trulicity	Dulaglutide	37	suppressed
Celecoxib	Celecoxib	36	11
Spironolactone	Spironolactone	36	14
Bupropion Hcl Sr	Bupropion Hcl	35	11
Fenofibrate	Fenofibrate Nanocrystallized	35	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	35	14
Ropinirole Hcl	Ropinirole Hcl	35	12
Glipizide	Glipizide	33	16
Alprazolam	Alprazolam	32	12
Januvia	Sitagliptin Phosphate	32	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	32	suppressed
Baclofen	Baclofen	30	suppressed
Fenofibrate	Fenofibrate	30	11
Zolpidem Tartrate	Zolpidem Tartrate	30	12
Esomeprazole Magnesium	Esomeprazole Magnesium	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Valsartan	Valsartan	28	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	18
Triamcinolone Acetonide	Triamcinolone Acetonide	27	23
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Amoxicillin	Amoxicillin	25	19
Azithromycin	Azithromycin	24	21
Methocarbamol	Methocarbamol	24	11
Sucralfate	Sucralfate	24	12
Advair Hfa	Fluticasone Propion/Salmeterol	23	suppressed
Enalapril Maleate	Enalapril Maleate	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Lovastatin	Lovastatin	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	22	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	17
Dicyclomine Hcl	Dicyclomine Hcl	22	11
Doxycycline Hyclate	Doxycycline Hyclate	22	18
Memantine Hcl	Memantine Hcl	22	suppressed
Nystatin	Nystatin	22	suppressed
Rybelsus	Semaglutide	22	suppressed
Finasteride	Finasteride	21	suppressed
Klor-Con M20	Potassium Chloride	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	20	suppressed
Varenicline Tartrate	Varenicline Tartrate	20	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Topiramate	Topiramate	19	suppressed
Tradjenta	Linagliptin	19	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Verapamil Er	Verapamil Hcl	18	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Entresto	Sacubitril/Valsartan	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Midodrine Hcl	Midodrine Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	15	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	15	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Dutasteride	Dutasteride	14	suppressed
Farxiga	Dapagliflozin Propanediol	14	suppressed
Levemir	Insulin Detemir	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Cephalexin	Cephalexin	13	13
Cilostazol	Cilostazol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Methylprednisolone	Methylprednisolone	13	11
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Naproxen	Naproxen	13	suppressed
Ozempic	Semaglutide	13	suppressed
Ramipril	Ramipril	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Dexmethylphenidate Hcl Er	Dexmethylphenidate Hcl	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error